Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.035 USD | -1.14% | -3.79% | -6.29% |
Apr. 24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
Apr. 08 | Gain Therapeutics Names Gene Mack as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 49.79M | |
+1.85% | 42.59B | |
+8.24% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.75% | 24.81B | |
-24.53% | 18.17B | |
+29.01% | 12.05B | |
-2.86% | 11.7B | |
+6.77% | 11.1B |
- Stock Market
- Equities
- GANX Stock
- News Gain Therapeutics, Inc.
- Gain Therapeutics : Names Matthias Alder COO